@semodough $ARWR could have 4 new PH1 initial dosing H2 2020, 3 of which are ex hepatic #RNAi (With some COVID cooperation). CEO mentioned 10 trials in PH1 or better by year end, 20 clinical studies in 2-3 years. #HBV data w/ $JNJ at #EASL next month. H2 2020 loaded with data and milestones